Renalytix Plc (LON:RENX – Get Free Report)’s stock price traded down 13.5% during trading on Monday . The company traded as low as GBX 7.55 ($0.10) and last traded at GBX 8 ($0.11). 360,311 shares were traded during trading, a decline of 25% from the average session volume of 478,805 shares. The stock had previously closed at GBX 9.25 ($0.12).
Renalytix Trading Down 5.9 %
The firm has a market capitalization of £13.27 million, a PE ratio of -27.86 and a beta of 2.10. The stock’s 50-day moving average price is GBX 11.81 and its 200 day moving average price is GBX 18.59. The company has a debt-to-equity ratio of 173.95, a current ratio of 0.42 and a quick ratio of 2.42.
About Renalytix
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Featured Articles
- Five stocks we like better than Renalytix
- How to Effectively Use the MarketBeat Ratings Screener
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- How Investors Can Find the Best Cheap Dividend Stocks
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- 5 discounted opportunities for dividend growth investors
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
